In July, the HudsonAlpha Institute for Biotechnology recently welcomed Dillon Fritz, PhD, as its new Vice President for Economic Development and Commercialization.
Fritz brings nearly two decades of experience building and leading translational research programs, innovation ecosystems, and startup ventures across the academic, clinical, and international biotech sectors. He most recently served as Entrepreneur-in-Residence and Director of the NIH-funded Gulf Coast Consortium Research Evaluation and Commercialization Hub (GCC REACH) at the Texas Medical Center in Houston, where he guided academic and clinical innovators in advancing early-stage biomedical technologies toward commercialization and venture formation. Prior to that, Fritz held several leadership roles including co-founder and CEO of a clinical genomics startup and as Head of the Bio Innovation and Translational Research Initiatives at King Abdullah University of Science and Technology (KAUST) in Saudi Arabia.
“We’re excited to welcome Dillon to the HudsonAlpha team,” said Neil Lamb, PhD, HudsonAlpha President. “We are energized by the depth of commercialization and translational background he brings to our economic development team.”
Fritz earned his undergraduate and doctoral degrees from Florida State University and Florida State University College of Medicine. He conducted his postdoctoral work as a National Cancer Institute Fellow at the Moffitt Cancer Center.
